NCT04434651 is a NA clinical trial of SPGB in Cerebral Tumor, sponsored by Zagazig University.

Who is sponsoring NCT04434651?

NCT04434651 is sponsored by Zagazig University.

What drugs are being tested in NCT04434651?

Interventions in NCT04434651: SPGB.

What condition does NCT04434651 study?

NCT04434651 studies Cerebral Tumor.

Is NCT04434651 still recruiting?

NCT04434651 is currently completed. Last updated 12 August 2021.

Last reviewed 2021-08-12 · How we verify

NCT04434651

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of SPGB on ICP and Oxygenation of Cerebral Venous Outflow in Craniotomy for Cerebral Tumors.

Completed NA Last updated 12 August 2021

What this trial tests

NA trial testing SPGB in Cerebral Tumor in 52 participants. Completed in 15 February 2021.

Timeline

17 June 2020

Primary endpoint
29 December 2020

15 February 2021

Quick facts

Lead sponsor	Zagazig University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	52
Start date	17 June 2020
Primary completion	29 December 2020
Estimated completion	15 February 2021
Sites	1 location across Egypt

Drugs / interventions tested

SPGB

Conditions studied

Cerebral Tumor — all drugs for Cerebral Tumor →

Sponsor

Zagazig University

Who can join

Adults 18 to 65, any sex, with Cerebral Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effect of Sphenopalatine Ganglion Block on ICP and arterio- jugular venous oxygen difference (AJVDO2) and jugular bulb oxygen saturation (SjVO2). Throughout this study, the efficacy of Sphenopalatine Ganglion Block as scalp block in craniotomy operation will be assessed, and the effect of SPGB on cerebral hemostasis during craniotomy will be evaluated by monitoring of both ICP, AJVDO2 and SjVO2.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of SPGB

Trials testing the same drug.

NCT04020393 — The Effect of Sphenopalatine Ganglion Block in Patients Undergoing Septorhinoplasty · completed

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04434651 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 12 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04434651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing